Plasmapheresis Market Size, Share, Growth Analysis, By Product(Instruments, disposables), By Technology(Centrifugation, membrane filtration), By Application(therapeutic plasmapheresis, source plasma collection), By End use(Biopharmaceutical companies, hospitals, clinics, others), By Region - Industry Forecast 2024-2031

Global Plasmapheresis Market size was valued at USD 1.15 billion in 2022 and is poised to grow from USD 1.24 billion in 2023 to USD 2.24 billion by 2031, growing at a CAGR of 7.7% in the forecast period (2024-2031).

Numerous macroeconomic and microeconomic factors are anticipated to have an impact on the worldwide plasmapheresis industry. Growth possibilities for market participants are projected to be brought on by an increase in global healthcare spending, particularly by the Middle East and Asia Pacific's growing emphasis on sophisticated medical care.

In addition to these elements, the market is projected to rise as people become more aware of the various alternatives for treating immune system illnesses, including myasthenia gravis, Guillain-Barre syndrome, Lyell's syndrome, systemic lupus erythematosus, and thrombotic thrombocytopenic purpura.

During the projection period, advancements in plasmapheresis together with expanding treatment options, such as veterinary healthcare, are projected to impact the market's future trajectory.

The worldwide plasmapheresis market is anticipated to grow by roughly 79 BPS between 2022 and 2028. It holds over 35.9% of the market share in the autoimmune disease diagnostic market, which is expected to develop at a 21.1% CAGR over the next several years.

Autoimmune illnesses are more prevalent among humans due to factors including pollution, the flu, and continual population growth. As a result, the demand for plasmapheresis has surged by double digits along with the need for other autoimmune disease therapies.

By the end of 2021, the market value for plasmapheresis had expanded by 4.6% CAGR to USD 1.2 billion. In the previous five years, the global plasmapheresis market produced close to USD 239 million. Additionally, it is anticipated to offer a total potential of more than USD 1.3 billion. The North American plasmapheresis market, which has provided an absolute monetary potential of almost USD 80 million over the past five years, dominates the worldwide industry. Compared to the 4.6% CAGR it saw between 2017 and 2021, the plasmapheresis market is anticipated to increase at a 7.4% CAGR between 2022 and 2028.

US Plasmapheresis Market is poised to grow at a sustainable CAGR for the next forecast year.